CVP alternating with fludarabine (CVP/F) chemotherapy prior to idiotype vaccination for follicular lymphoma (FL)

被引:0
|
作者
Ai, W. Z.
Hsu, F. J.
Timmerman, J. M.
Czerwinski, D.
Taidi, B.
Levy, R.
Horning, S.
机构
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Genzyme Corp, Framingham, MA 01701 USA
[3] Univ Calif Los Angeles, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
8065
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Mature outcomes for TROG 99.03: RCT of RT plus /- ( R)-CVP in Stage I-II Follicular Lymphoma
    MacManus, M.
    Seymour, J.
    Roos, D.
    O'Brien, P.
    Macann, A.
    Tsang, R.
    Davis, S.
    Shrestha, S.
    Joseph, D.
    Gandhi, M.
    Tobin, J.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S337 - S338
  • [22] THERAPY OF ADVANCED LYMPHOCYTIC LYMPHOMA A PRELIMINARY REPORT OF A RANDOMIZED TRIAL BETWEEN COMBINATION CHEMOTHERAPY (CVP) AND INTENSIVE RADIOTHERAPY
    CANELLOS, GP
    DEVITA, VT
    YOUNG, RC
    CHABNER, BA
    SCHEIN, PS
    JOHNSON, RE
    BRITISH JOURNAL OF CANCER, 1975, 31 : 474 - 480
  • [23] Cutaneous T-Cell Lymphoma in Tumor Stage - successful Treatment with Chemotherapy after CVP-Schema
    Liersch, J.
    Kuerle, S.
    Braun, S. A.
    Schulte, K. W.
    Homey, B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2010, 8 (11): : 957 - 957
  • [24] RANDOMIZED COMPARISON OF CHEMOTHERAPY (CVP) AND RADIOTHERAPY (TBI) IN STAGE III-IV POORLY DIFFERENTIATED LYMPHOCYTIC LYMPHOMA
    JOHNSON, RE
    CANELLOS, GP
    YOUNG, RC
    CHABNER, BA
    DEVITA, VT
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 : 33 - 33
  • [25] MabThera (Rituximab) plus cyclophosphamide, vincristine and prednisone (CVP) chemotherapy improves survival in previously untreated patients with advanced follicular non-Hodgkin's lymphoma (NHL).
    Marcus, Robert E.
    Solal-Celigny, Philippe
    Imrie, Kevin
    Catalano, John V.
    Dmoszynska, Anna
    Raposo, Joao C.
    Offner, Fritz C.
    Gomez-Codina, Jose
    BLOOD, 2006, 108 (11) : 146A - 146A
  • [26] The Prognosis Of Transformed Follicular Lymphoma Is Determined By Prior Exposure To Chemotherapy
    Jack, Andrew
    Smith, Alexandra
    de Tute, Ruth
    Painter, Daniel
    Roman, Eve
    Patmore, Russell
    BLOOD, 2013, 122 (21)
  • [27] R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature
    Ganguly Siddhartha
    Patel Vijay
    Journal of Hematology & Oncology, 2
  • [28] R-CHOP versus R-CVP in the treatment of follicular lymphoma: a meta-analysis and critical appraisal of current literature
    Siddhartha, Ganguly
    Vijay, Patel
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2009, 2
  • [29] Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma
    Marcus, Robert
    Imrie, Kevin
    Solal-Celigny, Philippe
    Catalano, John V.
    Dmoszynska, Anna
    Raposo, Joao C.
    Offner, Fritz C.
    Gomez-Codina, Jose
    Belch, Andrew
    Cunningham, David
    Wassner-Fritsch, Elisabeth
    Stein, George
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (28) : 4579 - 4586
  • [30] Fludarabine, cyclophosphamide and mitoxantrone (FCM) therapy in resistant or relapsed chronic lymphocytic leukemia (CLL) or follicular lymphoma (FL).
    Bosch, F
    Perales, M
    Cobo, F
    Esteve, J
    Rafel, M
    LopezGuillermo, A
    Ribera, JM
    Campo, E
    Montserrat, E
    BLOOD, 1997, 90 (10) : 2360 - 2360